An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

Herold, Kevan C ; Bundy, Brian N ; Long, S. Alice ; Bluestone, Jeffrey A ; DiMeglio, Linda A ; Dufort, Matthew J ; Gitelman, Stephen E ; Gottlieb, Peter A ; Krischer, Jeffrey P ; Linsley, Peter S ; Marks, Jennifer B ; Moore, Wayne ; Moran, Antoinette ; Rodriguez, Henry ; Russell, William E ; Schatz, Desmond ; Skyler, Jay S ; Tsalikian, Eva ; Wherrett, Diane K ; Ziegler, Anette-Gabriele ; Greenbaum, Carla J

The New England journal of medicine, 2019-08, Vol.381 (7), p.603-613 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível